REGN
Regeneron Pharmaceuticals, Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$745.77
-0.84 ▼ -0.11%
🌙 3월 13일 7:43 PM ET (한국 3/14 08:43)
$735.00
-10.77 ▼ -1.44%
| Index | NDX, S&P 500 | P/E | 17.94 | EPS (ttm) | 41.56 | Insider Own | 3.74% | Shs Outstand | 0.10B | Perf Week | -1.85% |
| Market Cap | 78.83B | Forward P/E | 14.08 | EPS next Y | 16.66% | Insider Trans | -0.33% | Shs Float | 0.10B | Perf Month | -4.26% |
| Enterprise Value | 73.19B | PEG | 1.27 | EPS next Q | 9.11 | Inst Own | 85.74% | Short Float | 2.25% | Perf Quarter | 2.69% |
| Income | 4.50B | P/S | 5.5 | EPS this Y | 2.45% | Inst Trans | 0.97% | Short Ratio | 2.88 | Perf Half Y | 31.25% |
| Sales | 14.34B | P/B | 2.52 | EPS next 5Y | 11.1% | ROA | 11.49% | Short Interest | 2.29M | Perf YTD | -3.38% |
| Book/sh | 295.71 | P/C | 9.15 | EPS past 3/5Y | 2.76% 6.33% | ROE | 14.87% | 52W High | -9.18% ($821.11) | Perf Year | 9.57% |
| Cash/sh | 81.46 | P/FCF | 19.32 | Sales past 3/5Y | 5.62% 11.04% | ROIC | 13.18% | 52W Low | 56.51% ($476.49) | Perf 3Y | -0.87% |
| Dividend Est. | $2.65 (0.36%) | EV/EBITDA | 17.24 | EPS Y/Y TTM | 5.49% | Gross Margin | 81.56% | Volatility(W/M) | 2.73% 2.8% | Perf 5Y | 58.18% |
| Dividend TTM | 3.58 | EV/Sales | 5.1 | Sales Y/Y TTM | 0.99% | Oper. Margin | 25.81% | ATR (14) | 22.9 | Perf 10Y | 97.75% |
| Dividend Ex-Date | 2026/2/20 | Quick Ratio | 3.39 | EPS Q/Q | -2.57% | Profit Margin | 31.41% | RSI (14) | 42.46 | Recom | 1.7 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.13 | Sales Q/Q | 2.51% | SMA20 | -4% ($776.84) | Beta | 0.41 | Target Price | $880.56 |
| Payout | 8.49% | Debt/Eq | 0.1 | Earnings | 1000000 | SMA50 | -3.14% ($769.95) | Rel Volume | 0.55 | Prev Close | $746.61 |
| Employees | 15410 | LT Debt/Eq | 0.09 | EPS/Sales Surpr. | 6.56% 1.93% | SMA200 | 15.36% ($646.47) | Avg Volume(3M) | 0.79M | Price | $745.77 |
| IPO | 1991/4/2 | Option/Short | Yes/Yes | Trades | 20234 | Volume | 438,297 | Change | -0.11% |
뉴스 로딩 중...